TGFB1 and breast carcinoma: Collectively, these experiments supported the notion that the secretion TGF-β1 by CAFs activated the TGF-β1/SMAD pathway in breast cancer cells, resulting in the up-regulation of HOTAIR transcription and histone modification of the CDK5 signaling pathway, thereby promoting breast cancer progression and metastasis.